Minerva Neurosciences, Inc.
NERV
$1.67
-$0.055-3.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 19.65M | 20.15M | 20.25M | 18.28M | 16.76M |
| Gross Profit | -19.65M | -20.15M | -20.25M | -18.28M | -16.76M |
| SG&A Expenses | 9.95M | 9.86M | 10.02M | 10.23M | 10.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.85M | 24.50M | 26.21M | 24.45M | 23.12M |
| Operating Income | -21.85M | -24.50M | -26.21M | -24.45M | -23.12M |
| Income Before Tax | 1.44M | -3.31M | -33.65M | -31.60M | -30.01M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.44 | -3.31 | -33.65 | -31.60 | -30.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.44M | -3.31M | -33.65M | -31.60M | -30.01M |
| EBIT | -21.85M | -24.50M | -26.21M | -24.45M | -23.12M |
| EBITDA | -21.84M | -24.49M | -26.21M | -24.45M | -23.11M |
| EPS Basic | 0.19 | -0.44 | -4.45 | -4.48 | -4.65 |
| Normalized Basic EPS | 0.12 | -0.27 | -2.78 | -2.80 | -2.91 |
| EPS Diluted | 0.19 | -0.44 | -4.45 | -4.48 | -4.65 |
| Normalized Diluted EPS | 0.12 | -0.27 | -2.78 | -2.80 | -2.91 |
| Average Basic Shares Outstanding | 30.28M | 30.28M | 30.28M | 28.22M | 25.99M |
| Average Diluted Shares Outstanding | 30.28M | 30.28M | 30.28M | 28.22M | 25.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |